US Stock MarketDetailed Quotes

SLDB Solid Biosciences

Watchlist
  • 8.1100
  • -0.4000-4.70%
Close Sep 6 16:00 ET
  • 8.1100
  • 0.00000.00%
Post 16:02 ET
313.01MMarket Cap-2465P/E (TTM)

Solid Biosciences Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
-40.57%8.09M
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
-40.57%8.09M
--0
--0
Cost of revenue
Gross profit
Operating expense
3.28%27.79M
-16.13%26.86M
-2.84%104.32M
-22.98%22.27M
9.38%23.11M
-10.41%26.91M
17.34%32.03M
25.03%107.37M
32.57%28.91M
-2.02%21.13M
Selling and administrative expenses
16.80%8.33M
7.97%7.99M
-4.13%27.75M
-10.58%6.81M
-10.03%6.41M
4.06%7.13M
0.64%7.4M
6.68%28.95M
5.64%7.62M
-0.22%7.13M
-General and administrative expense
16.80%8.33M
7.97%7.99M
-4.13%27.75M
-10.58%6.81M
-10.03%6.41M
4.06%7.13M
0.64%7.4M
6.68%28.95M
5.64%7.62M
-0.22%7.13M
Research and development costs
-1.60%19.46M
-23.38%18.87M
-2.37%76.56M
-27.42%15.45M
19.26%16.7M
-14.68%19.78M
23.49%24.63M
33.51%78.42M
45.87%21.29M
-2.91%14.01M
Operating profit
-3.28%-27.79M
16.13%-26.86M
-5.08%-104.32M
22.98%-22.27M
-9.38%-23.11M
-12.76%-26.91M
-26.24%-32.03M
-37.40%-99.27M
-54.99%-28.91M
-17.20%-21.13M
Net non-operating interest income expense
27.09%2.48M
52.32%2.56M
173.01%7.14M
8.15%1.66M
152.52%1.86M
565.19%1.95M
3,007.41%1.68M
3,987.50%2.62M
1.53M
735K
Non-operating interest income
24.51%2.57M
47.36%2.65M
173.01%7.14M
8.15%1.66M
152.52%1.86M
603.07%2.06M
--1.8M
3,987.50%2.62M
--1.53M
--735K
Non-operating interest expense
-20.72%88K
-21.49%95K
----
----
----
--111K
--121K
----
----
----
Other net income (expense)
-27.13%239K
-98.94%3K
-89.15%1.16M
-97.79%270K
2,238.46%278K
121.54%328K
2,920.00%282K
533,750.00%10.68M
55,659.09%12.22M
-127.08%-13K
Special income (charges)
--0
----
-99.43%63K
--0
--0
104.14%63K
----
--11.06M
--12.58M
--0
-Less:Restructuring and merger&acquisition
--0
----
99.43%-63K
--0
--0
-104.14%-63K
----
---11.06M
---12.58M
--0
Other non- operating income (expenses)
-9.81%239K
-98.94%3K
387.40%1.1M
176.06%270K
2,238.46%278K
8,933.33%265K
2,920.00%282K
-19,150.00%-381K
-1,513.64%-355K
-127.08%-13K
Income before tax
-1.80%-25.07M
19.18%-24.3M
-11.67%-96.02M
-34.22%-20.34M
-2.79%-20.98M
1.85%-24.63M
-18.72%-30.07M
-19.11%-85.98M
18.59%-15.15M
-13.50%-20.41M
Income tax
Net income
-1.80%-25.07M
19.18%-24.3M
-11.67%-96.02M
-34.22%-20.34M
-2.79%-20.98M
1.85%-24.63M
-18.72%-30.07M
-19.11%-85.98M
18.59%-15.15M
-13.50%-20.41M
Net income continuous Operations
-1.80%-25.07M
19.18%-24.3M
-11.67%-96.02M
-34.22%-20.34M
-2.79%-20.98M
1.85%-24.63M
-18.72%-30.07M
-19.11%-85.98M
18.59%-15.15M
-13.50%-20.41M
Minority interest income
Net income attributable to the parent company
-1.80%-25.07M
19.18%-24.3M
-11.67%-96.02M
-34.22%-20.34M
-2.79%-20.98M
1.85%-24.63M
-18.72%-30.07M
-19.11%-85.98M
18.59%-15.15M
-13.50%-20.41M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-1.80%-25.07M
19.18%-24.3M
-11.67%-96.02M
-34.22%-20.34M
-2.79%-20.98M
1.85%-24.63M
-18.72%-30.07M
-19.11%-85.98M
18.59%-15.15M
-13.50%-20.41M
Basic earnings per share
51.20%-0.61
58.44%-0.64
52.18%-4.83
-47.06%-1
61.25%-1.05
62.46%-1.25
54.30%-1.54
0.39%-10.1
72.31%-0.68
-12.86%-2.71
Diluted earnings per share
51.20%-0.61
58.44%-0.64
52.18%-4.83
-47.06%-1
61.25%-1.05
62.46%-1.25
54.30%-1.54
0.39%-10.1
72.31%-0.68
-12.86%-2.71
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000-40.57%8.09M00
Operating revenue --0--0--0--0--0--0--0-40.57%8.09M--0--0
Cost of revenue
Gross profit
Operating expense 3.28%27.79M-16.13%26.86M-2.84%104.32M-22.98%22.27M9.38%23.11M-10.41%26.91M17.34%32.03M25.03%107.37M32.57%28.91M-2.02%21.13M
Selling and administrative expenses 16.80%8.33M7.97%7.99M-4.13%27.75M-10.58%6.81M-10.03%6.41M4.06%7.13M0.64%7.4M6.68%28.95M5.64%7.62M-0.22%7.13M
-General and administrative expense 16.80%8.33M7.97%7.99M-4.13%27.75M-10.58%6.81M-10.03%6.41M4.06%7.13M0.64%7.4M6.68%28.95M5.64%7.62M-0.22%7.13M
Research and development costs -1.60%19.46M-23.38%18.87M-2.37%76.56M-27.42%15.45M19.26%16.7M-14.68%19.78M23.49%24.63M33.51%78.42M45.87%21.29M-2.91%14.01M
Operating profit -3.28%-27.79M16.13%-26.86M-5.08%-104.32M22.98%-22.27M-9.38%-23.11M-12.76%-26.91M-26.24%-32.03M-37.40%-99.27M-54.99%-28.91M-17.20%-21.13M
Net non-operating interest income expense 27.09%2.48M52.32%2.56M173.01%7.14M8.15%1.66M152.52%1.86M565.19%1.95M3,007.41%1.68M3,987.50%2.62M1.53M735K
Non-operating interest income 24.51%2.57M47.36%2.65M173.01%7.14M8.15%1.66M152.52%1.86M603.07%2.06M--1.8M3,987.50%2.62M--1.53M--735K
Non-operating interest expense -20.72%88K-21.49%95K--------------111K--121K------------
Other net income (expense) -27.13%239K-98.94%3K-89.15%1.16M-97.79%270K2,238.46%278K121.54%328K2,920.00%282K533,750.00%10.68M55,659.09%12.22M-127.08%-13K
Special income (charges) --0-----99.43%63K--0--0104.14%63K------11.06M--12.58M--0
-Less:Restructuring and merger&acquisition --0----99.43%-63K--0--0-104.14%-63K-------11.06M---12.58M--0
Other non- operating income (expenses) -9.81%239K-98.94%3K387.40%1.1M176.06%270K2,238.46%278K8,933.33%265K2,920.00%282K-19,150.00%-381K-1,513.64%-355K-127.08%-13K
Income before tax -1.80%-25.07M19.18%-24.3M-11.67%-96.02M-34.22%-20.34M-2.79%-20.98M1.85%-24.63M-18.72%-30.07M-19.11%-85.98M18.59%-15.15M-13.50%-20.41M
Income tax
Net income -1.80%-25.07M19.18%-24.3M-11.67%-96.02M-34.22%-20.34M-2.79%-20.98M1.85%-24.63M-18.72%-30.07M-19.11%-85.98M18.59%-15.15M-13.50%-20.41M
Net income continuous Operations -1.80%-25.07M19.18%-24.3M-11.67%-96.02M-34.22%-20.34M-2.79%-20.98M1.85%-24.63M-18.72%-30.07M-19.11%-85.98M18.59%-15.15M-13.50%-20.41M
Minority interest income
Net income attributable to the parent company -1.80%-25.07M19.18%-24.3M-11.67%-96.02M-34.22%-20.34M-2.79%-20.98M1.85%-24.63M-18.72%-30.07M-19.11%-85.98M18.59%-15.15M-13.50%-20.41M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -1.80%-25.07M19.18%-24.3M-11.67%-96.02M-34.22%-20.34M-2.79%-20.98M1.85%-24.63M-18.72%-30.07M-19.11%-85.98M18.59%-15.15M-13.50%-20.41M
Basic earnings per share 51.20%-0.6158.44%-0.6452.18%-4.83-47.06%-161.25%-1.0562.46%-1.2554.30%-1.540.39%-10.172.31%-0.68-12.86%-2.71
Diluted earnings per share 51.20%-0.6158.44%-0.6452.18%-4.83-47.06%-161.25%-1.0562.46%-1.2554.30%-1.540.39%-10.172.31%-0.68-12.86%-2.71
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg